Frontlight ResearchEarly access
Trial site
Cabinet Particular Policlinic Algomed S.R.L.
- 6running trials
- 3closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease6 trials
- Ulcerative colitis5 trials
- Phase
- Phase 25 trials
- Phase 34 trials
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting2 trials
- Lead sponsor
- AbbVie3 trials
- Takeda3 trials
- Sanofi-Aventis Recherche & Developpement2 trials
- Alvotech Swiss AG1 trial
Running trials
Recruiting
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Active, not recruiting
Recruiting
Active, not recruiting
A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease2 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Completed
A study to investigate efficacy and safety of SAR441566 in patients with Crohn's disease.
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026